Biogen: Run Lola Run?
July 24, 2015 at 14:09 PM EDT
When things go bad for a momentum stock, it gets real ugly real fast. Just look at Biogen (BIIB). At a recent $312.71, the share fell 18.7% in afternoon market action after earlier falling more than 20%. The biotech giant cut its full-year revenue and earnings guidance amid weakening prospects for its blockbuster multiple sclerosis [...]